➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Mallinckrodt
McKinsey
Moodys
Baxter

Last Updated: April 21, 2021

DrugPatentWatch Database Preview

CALCIUM CHLORIDE 10% Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Calcium Chloride 10%, and what generic alternatives are available?

Calcium Chloride 10% is a drug marketed by Am Regent, Intl Medication Sys, Medefil Inc, and Hospira. and is included in four NDAs.

The generic ingredient in CALCIUM CHLORIDE 10% is calcium chloride. There are two hundred and eighty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the calcium chloride profile page.

Summary for CALCIUM CHLORIDE 10%
Drug patent expirations by year for CALCIUM CHLORIDE 10%
Pharmacology for CALCIUM CHLORIDE 10%

US Patents and Regulatory Information for CALCIUM CHLORIDE 10%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 209088-001 Jul 27, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER calcium chloride INJECTABLE;INJECTION 021117-001 Jan 28, 2000 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Intl Medication Sys CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 203477-001 May 9, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Medefil Inc CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 211553-001 May 1, 2019 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Moodys
McKinsey
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.